Research Division Type 1 Diabetes Immunology, Helmholtz Diabetes Center at Helmholtz Zentrum München, 80939 Munich, Germany; Deutsches Zentrum für Diabetesforschung (DZD), 85764 Munich, Germany.
Research Division Type 1 Diabetes Immunology, Helmholtz Diabetes Center at Helmholtz Zentrum München, 80939 Munich, Germany; Deutsches Zentrum für Diabetesforschung (DZD), 85764 Munich, Germany; Division of Clinical Pharmacology, Department of Medicine IV, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
Cell Metab. 2024 Feb 6;36(2):229-239. doi: 10.1016/j.cmet.2023.12.019. Epub 2024 Jan 12.
Tissue regulatory T cells (Tregs) exert pivotal functions in both immune and metabolic regulation, maintaining local tissue homeostasis, integrity, and function. Accordingly, Tregs play a crucial role in controlling obesity-induced inflammation and supporting efficient muscle function and repair. Depending on the tissue context, Tregs are characterized by unique transcriptomes, growth, and survival factors and T cell receptor (TCR) repertoires. This functional specialization offers the potential to selectively target context-specific Treg populations, tailoring therapeutic strategies to specific niches, thereby minimizing potential side effects. Here, we discuss challenges and perspectives for niche-specific Treg targeting, which holds promise for highly efficient and precise medical interventions to combat metabolic disease.
组织调节性 T 细胞(Tregs)在免疫和代谢调节中发挥关键作用,维持局部组织的稳态、完整性和功能。因此,Tregs 在控制肥胖引起的炎症和支持有效的肌肉功能和修复中起着至关重要的作用。根据组织环境的不同,Tregs 具有独特的转录组、生长和存活因子以及 T 细胞受体(TCR)库。这种功能特化提供了选择性靶向特定微环境 Treg 群体的潜力,从而使治疗策略针对特定龛位,从而最大限度地减少潜在的副作用。在这里,我们讨论了针对特定微环境 Treg 靶向的挑战和前景,这为对抗代谢疾病的高效和精确的医学干预提供了可能。